PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,316,347
|
mir retrotransposon link epigenom transcriptom code gene acut myeloid leukemia dnmta idh mutat combinator regul transcriptom epigenom acut myeloid leukemia yet mechan interplay unknown use system approach within topolog associ domain find gene signific express methyl correl enrich signal metabol pathway common denomin across methyl regul gene densiti mir retrotransposon intron moreov discret number cpgs overlap enhanc respons regul gene establish mous model recapitul depend mir rich gene balanc express epigenet modifi project leukem profil onto normal hematopoiesi one consolid depend methyl regul gene mir collect mir element gene enhanc suscept chang dna methyl activ explain cooper protein pathway normal malign hematopoiesi
|
D000081122;D015470
|
T191;T028
|
36,316,345
|
lifesnap month multi modal dataset captur unobtrus snapshot live wild ubiquit self track technolog penetr various aspect live physic mental health monitor fit entertain yet limit data exist associ wild larg scale physic activ pattern sleep stress overal health behavior psycholog pattern due challeng collect releas dataset includ wane user engag privaci consider paper present lifesnap dataset multi modal longitudin geograph distribut dataset contain plethora anthropolog data collect unobtrus total cours month n particip lifesnap contain differ data type second daili granular total row data particip contribut data valid survey ecolog momentari assess fitbit sens smartwatch consent make data avail empow futur research envis releas larg scale dataset multi modal real world data open novel research opportun potenti applic multipl disciplin
|
D000072860;D008603
|
T060;T041
|
36,316,343
|
hierarch transcript factor cascad regul enteroendocrin cell divers plastic drosophila enteroendocrin cell ee repres heterogen cell popul intestin exert endocrin function secret divers array neuropeptid although mani transcript factor tfs requir specif ee identifi mammal drosophila understood tfs work togeth generat consider subtyp divers show ee divers adult drosophila generat via addit hierarch tf cascad specif combin master tf secondari level tf tertiari level tf constitut tf code generat ee divers also discov high degre post specif plastic ee chang code includ one distinct tf allow effici switch subtyp ident studi thus reveal hierarch organ tf code under ee divers plastic drosophila guid investig ee mammal inform applic medicin
|
D004330;D029721
|
T123;T116;T204
|
36,316,342
|
explor speci level infant gut bacteri biodivers meta analysi formul optim cultiv medium vitro gut cultiv model provid host uncoupl fast cost effici solut investig effect intrins extrins factor impact composit function intestin microbi ecosystem howev ensur mainten surviv gut microbi player preserv function system requir close monitor sever variabl includ oxygen concentr ph temperatur well use cultur medium satisfi microbi nutrit requir context order identifi macro micro nutrient necessari vitro cultiv infant gut microbiota meta analysi base public avail shotgun metagenom sampl correspond fecal sampl healthi full term infant age day three year perform defin predomin speci character infant like gut microbi ecosystem subsequ comparison growth perform made use infant fecal sampl contain abund bacteri taxa infant gut microbiota cultiv differ cultur media growth analysi perform mean flow cytometri base bacteri cell enumer shallow shotgun sequenc allow formul optim growth medium ie infant gut super medium igsm maintain sustain infant gut microbi biodivers vitro growth condit furthermor formul use evalu vitro effect two drug common use pediatr ie acetaminophen simethicon taxonom composit infant gut microbiota
|
D000069196
|
T007;T001
|
36,316,341
|
efficaci safeti apatinib patient recurr metastat head neck squamous cell carcinoma retrospect multi center studi apatinib novel antiangiogen agent target vascular endotheli growth factor aim studi explor efficaci safeti apatinib treatment patient recurr metastasi rm inoper head neck squamous cell carcinoma hnscc multi center retrospect studi analyz case recurr metastat inoper hnscc progress recur undergo standard radiotherapi chemotherapi immunotherapi treat apatinib march august patient continu apatinib time diseas progress onset intoler advers event primari endpoint progress free surviv pfs secondari endpoint overal surviv os object respons rate orr diseas control rate dcr incid advers event univari multivari analys perform determin prognost factor main advers event count sever advers reaction evalu fifti three patient recurr metastat inoper rm hnscc progress recur standard radiotherapi chemotherapi immunotherapi includ orr dcr median pfs month confid interv ci month median os month ci month number apatinib line influenc factor pfs os eastern cooper oncolog group ecog score tumor differenti apatinib durat influenc factor os ecog score independ predictor os common advers reaction hypertens hand foot syndrom fatigu oral ulcer nausea vomit advers reaction grade apatinib mesyl good efficaci recurrentmetastat inoper hnscc second line line treatment ecog score independ prognost factor os patient treat apatinib addit advers effect apatinib mesyl relat mild
|
D000970;D006258;D000077195
|
T121;T191;T109
|
36,316,339
|
drug transport oat oat specif effect multipl organ gut microbiom reveal contextu metabol network reconstruct vitro vivo studi establish organ anion transport oat slca nkt oat slca among main multi specif drug transport also transport numer endogen metabolit rais possibl drug metabolit interact dmi help understand role drug transport metabol across scale rang organ system organell formal multi scale analysi perform metabol network reconstruct omic alter result oat oat gene knockout reveal link microbiom human metabol includ reaction involv small organ molecul dihydroxyaceton alanin xanthin p cresol key metabolit independ pathway interest pairwis organ organ interact also disrupt two oat knockout alter liver intestin microbiom skin relat metabol compar older model focus one transport one organ concept sophist reconstruct combin integr multi microbi model comprehens metabolom data two transport provid consider complex pictur renal drug transport regul metabol across organell eg endoplasm reticulum golgi peroxisom cellular organ inter organ inter organism scale result suggest drug interact oat oat far reach consequ metabol organ eg skin beyond kidney consist remot sens signal theori rsst analysi demonstr transport depend metabol signal mediat organ crosstalk eg gut liver kidney inter organism communic eg gut microbiom host
|
D000069196;D027362;D029362
|
T123;T007;T116;T001
|
36,316,338
|
network infer perturb time cours data network underli much biolog subcellular ecolog scale yet understand experiment data need use unambigu identifi structur even small network remain broad challeng integr dynam least squar framework establish modular respons analysi dl mra specifi suffici experiment perturb time cours data robust infer arbitrari two three node network dl mra consid import network properti current method often struggl captur edg sign direct ii cycl feedback feedforward loop includ self regul iii dynam network behavior iv edg extern network v robust perform experiment nois evalu perform extent approach appli cell state transit network intracellular signal network gene regulatori network although signal network often applic network reconstruct method result suggest quit restrict condit robust infer gene regulatori network result suggest incomplet knockdown often inform full knockout perturb may chang experiment strategi gene regulatori network reconstruct overal result give ration basi experiment data requir network reconstruct appli problem perturb time cours experi possibl
|
D049490;D000465
|
T170;T091
|
36,316,337
|
analysi rhizospher bacteri communiti tobacco resist non resist bacteri wilt differ region tobacco bacteri wilt serious affect tobacco product ethyl methanesulfon em induc tobacco bacteri wilt resist mutant import control tobacco bacteri wilt high throughput sequenc technolog use studi rhizospher bacteri communiti assemblag bacteri wilt resist mutant tobacco rhizospher soil name ks bacteri wilt suscept tobacco rhizospher soil name gs bulk soil name bs xuancheng huanxi yibin luzhou alpha analysi show bacteri communiti divers rich ks gs four region signific differ howev analysi intergroup variat top bacteri communiti term abund show bacteri communiti ks gs signific differ bs respect addit ph alkali hydrolys nitrogen soil organ carbon soc posit correl bacteri communiti ks negat correl gs three region except huanxi network analysi show three soil four region show consist pattern network complex picrust function predict analysi show cog function similar sampl coloni involv rna process modif chromatin structur dynam etc conclus experi show rhizospher bacteri communiti tobacco differ region differ composit pattern strong relat soil factor
|
D058441;D014026
|
T070;T002
|
36,316,336
|
unexpect assembl machineri h quinazolinon scaffold synthesi h quinazolinon core scaffold natur alkaloid numer drug mani chemosynthet methodolog develop generat howev investig nativ enzymat format mechan fungi larg limit fumiquinazolin two nitrogen atom come anthranil n nh amino acid n via biochem investig chrysogin pathway unexpect assembl machineri h quinazolinon unveil involv fungal two modul nonribosom peptid synthas ftchya unusu termin condens domain catalys tripeptid format reveal n origin inorgan ammonium ion amid l gln demonstr unusu ketoglutar depend dioxygenas ftchym catalysi c n bond oxid cleavag tripeptid form dipeptid studi uncov uniqu releas tailor mechan nonribosom peptid altern rout synthesi h quinazolinon scaffold
|
D010453;D000470
|
T123;T121;T116;T109;T131;T126
|
36,316,334
|
circular rna circbnc inhibit epitheli cell g arrest prevent fibrot maladapt repair mechan under fibrogen respons injuri well understood epitheli cell cycl arrest gm injuri key checkpoint determin wound heal lead either normal cell prolifer fibrosi identifi kidney liver enrich circular rna circbnc abund express normal renal tubular cell hepatocyt signific downregul acut ischem toxic insult loss circbnc least partial mediat upregul dhx gain loss function studi vitro vivo demonstr circbnc act negat regul cell gm arrest encod protein promot format cdkcyclin b complex restor circbnc experiment induc male mous model fibrot kidney liver decreas gm arrest cell number secret fibrot factor therebi mitig extracellular matrix deposit fibrosi decreas express circbnc increas gm arrest epitheli cell recapitul human ischem reperfus injuri iri induc chronic kidney diseas inflamm induc liver fibrosi highlight clinic relev find suggest restor circbnc might repres potenti strategi therapeut intervent epitheli organ fibrosi
|
D000079962;D051436
|
T047;T114
|
36,316,329
|
volcan host vent indic ultramaf influenc aurora hydrotherm field gakkel ridg aurora hydrotherm system arctic ocean host activ submarin vent within extens field relict miner deposit show site associ neovolcan mound locat within gakkel ridg rift valley floor deep tow camera sidescan survey reveal site across unusu larg volcan host vent slow spread ridg compar tecton host system requir larg time integr heat flux form hydrotherm plume eman aurora exhibit much higher dissolv ch mn valu typic basalt host hydrotherm system instead close resembl high temperatur ultramaf influenc vent slow spread ridg hypothes deep penetr fluid circul may sustain prolong vent evid aurora hydrotherm field hydrotherm convect cell access ultramaf litholog under anomal thin ocean crust ultraslow spread ridg set find implic ultra slow ridg cool global marin miner distribut divers geolog set host abiot organ synthesi pertin search life beyond earth
|
D012623;D060086
|
T070;T167
|
36,316,327
|
role reactiv oxygen speci regul hydroxycholesterol induc apoptosi hematopoiet progenitor cell myeloid cell line oxysterol oxygen deriv cholesterol contain addit hydroxi epoxid keton group sterol nucleus andor hydroxyl group side chain cholesterol molecul hydroxycholesterol hc side chain oxysterol oxygen th carbon atom cholesterol oxysterol hc produc via oxid sterol hydroxylas cypa metabol via oxysterol hydroxylas cypb bile acid synthesi liver previous studi demonstr treatment altern estrogen receptor alpha er ligand hc induc er depend hematopoiet stem cell hsc mobil addit cypa defici mice demonstr signific reduc hc level hsc mobil report exogen hc treatment lead substanti reduct hematopoiet stem progenitor cell hspc popul owe signific increas reactiv oxygen speci ros level apoptosi bone marrow bm howev hc influenc popul matur hematopoiet cell bm furthermor exogen hc treatment suppress cell growth promot ros product apoptosi leukem cell moreov acut myeloid leukemia aml patient high cypb express expect inhibit hc signific shorter surviv low cypb express expect elev hc singl cell rna sequenc scrna seq analysi reveal express cypb signific increas aml patient thus studi suggest hc may serv potent agent regul pool hspcs may applic novel therapeut target hematolog malign collect pharmacolog inhibit cypb expect elev hc would potenti fewer long term hematolog side effect particular use combin chemotherapi radiat treatment leukemia patient
|
D047628;D000072376
|
T123;T109;T116;T192
|
36,316,324
|
two kind transcript factor mediat chronic morphin induc decreas mir medial prefront cortex rat chronic morphin administr alter gene express differ brain region effect may contribut plastic chang associ addict behavior chang gene express possibl mediat addict drug induc epigenet remodel gene express program previous studi show chronic morphin induc decreas mir medial prefront cortex mpfc contribut context induc retriev morphin withdraw memori howev chronic morphin treatment decreas mir mpfc still remain unknown present studi show chronic morphin induc addict relat chang mir mpfc via two kind transcript factor first transcript factor creb activ mu receptor erk prsk signal pathway second transcript factor glucocorticoid receptor gr negat transcript factor mediat chronic morphin induc decreas mir mpfc rat
|
D035683;D009020;D017397;D014157
|
T123;T121;T029;T116;T109;T030;T114;T023
|
36,316,322
|
thioredoxin interact protein defici protect sever acut pancreat suppress apoptosi signal regul kinas acut pancreat common acut inflammatori abdomin diseas acut pancreat progress sever acut pancreat sap lead system inflamm even multipl organ failur thioredoxin interact protein txnip import protein involv redox reaction inflammatori respons howev specif role txnip sap remain unclear studi investig role thioredoxin interact protein txnip acut pancreat induc high dose arginin found pancreat damag inflammatori respons associ acut pancreat larg restrain txnip knock mice enhanc mice overexpress txnip interest phosphoryl p jnk ask diminish txnip ko mice pancreat comparison wild type mice role oxid stress sap explor two model txnip avv txnip txnip knockdown inhibit ask gs abrog increas p p p jnk p ask arj cell incub l arg administr gs mice pancreat larg reduc upregul il il tnf mcp system inflammatori reaction injuri lung kidney assess txnip ko avv txnip mice expect outcom conclus txnip novel mediat sap exert action regul inflammatori respons oxid stress via ask depend activ jnkp pathway thus target txnip may repres promis approach protect sap
|
D048848;D010195;D011488;D013879
|
T123;T116;T126;T047;T046
|
36,316,320
|
translat natur select micropeptid long non canon rnas long noncod rnas lncrnas transcript longer nucleotid lack canon code sequenc appar unabl produc peptid lncrna function seem reli rna express sequenc structur exhaust detect vivo translat small open read frame small orf within lncrnas use ribosom profil drosophila melanogast embryogenesi show around lncrnas contain small orf engag ribosom lead regul translat micropeptid identifi lncrna featur favour translat cistron kozak sequenc conserv latter develop bioinformat pipelin detect small orf homologu reveal evid natur select favour conserv micropeptid sequenc function across evolut result expand repertoir lncrna biochem function suggest lncrnas give rise novel code gene throughout evolut sinc lncrnas contain small orf yet unknown translat potenti propos renam long non canon rnas
|
D062085
|
T123;T114
|
36,316,319
|
nrf regul arginas microglia phenotyp initi trem transcript amelior depress like behavior mice express trigger receptor myeloid cell trem knockdown microglia later habenula lhb report induc depress like behavior mice howev key molecular mechan mediat major depress disord mdd pathogenesi remain elus herein show nrf regul trem transcript effect trem mrna protein express activ nrf sulforaphan nrf activ increas microgli arginas phenotyp initi trem transcript medial prefront cortex mpfc amelior depress like behavior csds mice knockout nrf decreas trem microgli arginas phenotyp mpfc nrf ko mice depress like behavior downregul trem express decreas microgli arginas phenotyp mpfc result depress like behavior sfn treat csds mice final knockout nrf downregul trem express decreas microgli arginas phenotyp mpfc nrf ko mice sfn treat csds mice associ brain deriv neurotroph factor bdnf tropomyosin receptor kinas b trkb signal pathway data indic alter interact nrf trem may play role pathophysiolog depress like behavior mice
|
D017628;D003865
|
T025;T048
|
36,316,316
|
plasma membran flip syntaxin regul inhibitori action insulin granul exocytosi enhanc pancreat cell secret primari therapeut target type diabet td syntaxin stx identifi inhibitori snare insulin granul exocytosi hold potenti treatment td yet molecular underpin remain unclear show excess stx recruit raft like granul dock site higher bind affin pro fusion syntaxin effect compet inhibit fusogen snare machineri deplet stx human cell improv insulin secret enhanc tran snare complex assembl cis snare disassembl use genet encod report glucos stimul shown induc stx flip across plasma membran reliev suppress cytoplasm fusogen snare complex promot insulin secret target flip effici stx profound modul secret could restor impair insulin secret diabet show stx act assist precis tune insulin secret cell includ diabet
|
D007328;D003924
|
T125;T121;T047;T116
|
36,316,315
|
multidimension memori topographi medial pariet cortex identifi neuroimag thousand daili memori video memori form tapestri event peopl place woven across decad live howev research often limit assess natur episod memori use artifici stimuli short time scale explos social media enabl new way examin neural represent naturalist episod memori featur like memori age locat memori strength emot recruit user video diari app everyday record daili memori video span year fmri scan particip view memori video intermix anoth individu find memori featur tight interrel highlight need test conjunct discov multidimension topographi medial pariet cortex subregion sensit memori age strength familiar peopl place involv
|
D061212
|
T041
|
36,316,313
|
target activ gper enhanc efficaci venetoclax boost leukem pyroptosi cd cell immun function acut myeloid leukemia acut myeloid leukemia aml rapid progress often fatal hematopoiet malign venetoclax ven recent fda approv bcl select inhibitor high initi respons rate elder aml patient major patient eventu acquir resist multipl studi demonstr femal sex associ better outcom patient aml predomin attribut estrogen signal novel membran estrogen receptor g protein coupl estrogen receptor gper mediat rapid estrogen effect attract consider attent howev whether target gper enhanc antileukem activ ven unknown studi first demonstr gper express dramat reduc aml cell owe promot hypermethyl furthermor pharmacolog activ gper g combin ven result synergist antileukem activ vitro vivo mechanist g ven combin synergist trigger concurr mitochondria relat apoptosi gasdermin e gsdme depend pyroptosi activ p mapkmyeloid cell leukemia mcl axi import leukem pyroptosi heighten cd cell immun function releas interleukin il tumor microenviron studi corrobor gper activ show synergist antileukem effect ven make promis therapeut regimen aml
|
D011960;D015470
|
T191;T116;T192
|
36,316,312
|
effect granulocyt coloni stimul factor toxic car cell therapi lymphoma myeloma chimer antigen receptor cell car groundbreak therapi may caus signific toxic includ cytokin releas syndrom crs immun effector cell associ neurotox syndrom ican cytopenia granulocyt coloni stimul factor g csf often use mitig neutropenia car consensus recommend strategi due hypothes larg unknown risk exacerb toxic investig impact g csf retrospect analyz patient treat anti cd car lymphoma patient treat anti bcma car multipl myeloma lymphoma patient receiv prophylact g csf car most pegyl g csf compar patient treat g csf car expos prophylact g csf associ faster neutrophil recoveri vs day p reduc recurr neutropenia later prophylact g csf associ increas grade crs hr ci p ican multipl myeloma prophylact g csf use patient stratifi earli g csf exposur day vs day car exposur signific differ toxic futur trial clarifi optim g csf strategi improv outcom car
|
D016179;D016219;D008223;D009101
|
T061;T129;T191;T116
|
36,316,311
|
advanc regen medicin applic tetrahedr framework nucleic acid base nanomateri expert consensus recommend emerg dna nanotechnolog self assembl dna nanostructur attract consider attent worldwid due inher biocompat unsurpass programm versatil function especi promis nanostructur tetrahedr framework nucleic acid tfnas first propos turberfield use one step anneal approach benefit various merit simpl synthesi high reproduc structur stabil cellular intern tissu permeabl edit function tfnas wide appli biomed field three dimension dna nanomateri surpris tfnas exhibit posit effect cellular biolog behavior tissu regener may use treat inflammatori degen diseas accord intend applic carri capac tfnas could carri function nucleic acid therapeut molecul extend sequenc sticki end hybrid intercal encapsul base watson crick principl addit dynam tfnas also potenti applic control target therapi review summar latest progress puremodifieddynam tfnas demonstr regen medicin applic applic includ promot regener bone cartilag nerv skin vasculatur muscl treat diseas bone defect neurolog disord joint relat inflammatori diseas periodont immun diseas
|
D009696
|
T123;T114
|
36,316,310
|
veget type import predictor arctic summer land surfac energi budget despit import high latitud surfac energi budget seb land climat interact rapid chang arctic uncertainti predict persist harmon seb observ across network veget glaciat site circumpolar scale varianc partit analysi identifi veget type import predictor seb compon arctic summer june august compar seb driver includ climat latitud permafrost characterist differ among veget type similar magnitud veget glacier surfac especi high summer sensibl latent heat flux time seb flux summer regim daili mean valu exceed wm relat snow free onset date vari substanti depend veget type impli veget control snow cover seb flux season result indic complex shift surfac energi flux land cover transit lengthen summer season highlight potenti improv futur earth system model via refin represent arctic veget type
|
D017753;D065946
|
T083;T167;T070;T082
|
36,316,309
|
format supramolecular channel revers unwind rewind bis indol doubl helix via ion coordin stimulus respons revers transform two structur conform essenti process mani biolog system exampl process convers amyloid peptid sheet rich oligom lead accumul insolubl amyloid brain alzheim diseas revers uniqu structur shift prevent amyloid accumul sheet breaker use herein report seri bis indol base biofunct molecul form stabl doubl helix structur solid solut state presenc chlorid anion doubl helic structur unwind form anion coordin supramolecular polymer channel turn rewind upon addit ag salt moreov format anion induc supramolecular ion channel result effici ion transport across lipid bilay membran excel chlorid select work demonstr anion cation assist stimulus respons unwind rewind artifici doubl helix system pave way smart materi better biomed applic
|
D002712;D016229
|
T196;T034;T116
|
36,316,305
|
brca mutat status shape stromal microenviron pancreat cancer link clusterin express cancer associ fibroblast hsf signal tumor initi mutat cancer cell progress interact cancer cell non malign cell tumor microenviron major player tumor microenviron cancer associ fibroblast caf support tumor malign compris tumor mass pancreat cancer caf transcript rewir cancer cell whether rewir differenti affect differ mutat cancer cell larg unknown address question dissect stromal landscap brca mutat brca wild type pancreat ductal adenocarcinoma comprehens analyz pancreat cancer sampl patient reveal differ caf subtyp composit germlin brca mutat vs brca wild type tumor particular detect increas subset immun regulatori clusterin posit caf brca mutat tumor use cancer organoid mous model show process mediat activ heat shock factor transcript regul clusterin find unravel dimens stromal heterogen influenc germlin mutat cancer cell direct implic clinic research
|
D000072645;D021441;D051152;D000076249;D010190
|
T129;T123;T025;T116;T191
|
36,316,301
|
hyperspectr imag tumor segment pigment skin lesion significancemalign skin tumor includ melanoma nonmelanoma skin cancer preval type malign tumor gross patholog pigment skin lesion psl remain manual time consum heavili depend expertis medic personnel hyperspectr imag hsi assist detect tumor evalu status tumor margin spectral signaturesaimtumor segment medic hsi data research field goal studi propos framework hsi base tumor segment pslapproachan hsi dataset psl prepar two framework data preprocess tumor segment propos model base machin learn deep learn use core frameworkresultscross valid perform show pixel wise process achiev higher segment perform term jaccard coeffici simultan use spatio spectral featur produc comprehens tumor mask three dimension xception base network achiev perform similar state art network allow detail detect tumor borderconclusionsgood perform achiev melanocyt lesion margin difficult detect case basal cell carcinoma framework propos studi could improv robust differ patholog detail delin tissu margin facilit comput assist diagnosi gross patholog
|
D008545;D012878
|
T191
|
36,316,298
|
vivo spectroscop evalu human tissu optic properti hemodynam hpph mediat photodynam therapi pleural malign significancedosimetri photodynam therapi depend multipl paramet critic vivo tissu optic properti hemodynam must determin care calcul total deliv light doseaimspectroscop analysi diffus reflect measur tissu taken clinic trial hexyloxyethyl devinyl pyropheophorbid mediat photodynam therapi pleural malignanciesapproachdiffus reflect measur taken immedi photodynam therapi measur analyz nonlinear constrain multiwavelength multi distanc algorithm extract tissu optic properti tissu oxygen satur sto total hemoglobin concentr thc resultsa total patient measur produc reliabl fit optic properti extract tissu type sto rang pre photodynam therapi pdt post pdt condit respect mean thc rang pre pdt post pdt respect absorpt coeffici rang cm cm pre pdt post pdt condit respect reduc scatter coeffici rang cm cm pre pdt post pdt condit respectivelyconclusionsther similar pre post pdt tissu optic properti hemodynam high variabl paramet tissu type emphas import measur accur pdt dosimetri
|
D010778;D010997
|
T061;T191
|
36,313,542
|
contradictori effect coffe intak periodont health systemat review background drink coffe known posit negat aftermath periodont health current studi aim systemat review impact coffe consumpt periodont health status method articl search carri two electron databas pubm web scienc assess includ articl conduct use joanna brigg institut jbi critic apprais tool data analyz qualit result total articl includ studi studi discov negat correl coffe intak periodont health studi found protect effect daili coffe consumpt alveolar bone loss last one studi found coffe intak relat periodont conclus effect coffe consumpt periodont health fragment sinc coffe complex compon may give either benefici effect negat impact periodont health
|
D003069;D010518
|
T168;T047
|
36,226,037
|
genet function signific understudi methamphetamin sensit circadian oscil masco last year wit extraordinari discoveri field circadian rhythm howev still sever mysteri remain one chronobiolog mysteri circadian rhythm reveal administr stimul drug rodent herein describ discoveri circadian rhythm under oscil frequent call methamphetamin sensit circadian oscil masco oscil distinct canon circadian oscil control robust activ rhythm independ suprachiasmat nucleus circadian gene essenti timekeep discuss fundament properti masco integr studi strain sex circadian gene mutat masco anatom loci masco known possibl thus far discov novel molecular timekeep mechan function signific howev studi mutant mice suggest genet approach use identifi neural network involv rhythm generat masco also discuss parallel human rodent studi support work hypothesi function masco may regul sleep wake cycl
|
D008694;D000697
|
T121;T131;T109
|
36,316,265
|
obes children child obes wide preval general pediatrician play import role identifi care patient obes appropri evalu treatment requir understand complex etiolog child obes intergener transmiss epidemiolog trend includ racialethn socioeconom dispar american academi pediatr publish screen evalu treatment guidelin base best avail evid howev gap evid remain implement evid base recommend challeng import review optim care primari care multidisciplinari weight manag set allow time evalu appropri referr pediatrician play key role advoc patient higher risk also role larger scale prevent polici measur would aid pediatrician manag obes great benefit child health popul scale
|
D063766
|
T033;T047
|
36,316,262
|
care children incarcer parent age one fourteen american children parent incarcer although children background experi parent incarcer racial ethnic minor group live poverti disproportion affect parent incarcer advers childhood experi negat affect health well life cours howev resili children incarcer parent flourish despit profound advers pediatr provid creat safe inclus medic home foster sensit disclosur discuss parent incarcer pediatr provid identifi parent incarcer promot foundat relationship famili resili includ relationship incarcer parent appropri consid referr mental health specialist special program children incarcer parent pediatr provid also uniqu posit advoc partnership polici support children incarcer parent
|
D011329;D055500
|
T055;T098
|
36,316,261
|
anxieti disord children anxieti disord common mental health disord children clear defin empir base treatment howev assess treatment pose sever obstacl pediatr provid child may age appropri communic skill still struggl accur report presenc time sever symptom report parent caregiv teacher often subject focus aspect child behavior untreat anxieti disord advers effect child function impair physic health academ perform social compet lead lifelong consequ well valid rapid administ screen tool use gather data school resourc inform diagnosi guid treatment recommend track improv limit train behavior health diagnosi fear black box warn left mani pediatr clinician reluct prescrib medic readili avail practic guidelin medic data document efficaci medic children encourag use
|
D010290;D005190
|
T099;T062;T079;T102;T054
|
36,316,254
|
updat late onset sepsi risk assess therapi outcom neonat late onset sepsi los continu threaten morbid mortal nicu pose ongo diagnost therapeut challeng earli recognit clinic sign rapid evalu prompt initi treatment critic prevent life threaten deterior preterm infant born ever decreas gestat age particular high risk life long morbid death chang nicu popul necessit continu reassess diagnost prevent measur evid base treatment los clinic present los vari nonspecif despit ongo research reliabl specif laboratori biomark facilit earli diagnosi lack limit drive ongo practic liber initi empir antibiot among infant suspect los subsequ promot multidrug resist microorgan threaten futur antimicrobi therapi put preterm chronic ill infant even higher risk nosocomi infect effort identifi adjunct therapi counteract sepsi driven hyperinflamm sepsi relat function immunosuppress ongo howev approach either fail improv los prognosi yet readi clinic applic articl provid overview epidemiolog risk factor diagnost tool treatment option los context increas number extrem preterm infant address question whether los could identifi earlier precis allow earlier target therapi discuss ration approach antibiot therapi avoid overus final review elucid necess long term follow infant histori los
|
D000071074;D018805
|
T047;T046
|
36,316,253
|
neonat earli onset sepsi earli onset sepsi eo signific caus morbid mortal among newborn infant particular among born prematur epidemiolog eo chang time highlight contemporari data inform epidemiolog neonat eo includ incid microbiolog risk factor associ outcom focus infant born high incom countri birth hospit discuss approach risk assess eo summar nation guidelin compar key differ approach term preterm infant last analyz contemporari antibiot resist data eo pathogen inform optim empir treatment eo
|
D000071074;D018805;D007235
|
T047;T046
|
36,316,208
|
new onset diabet mellitus weight loss manifest pancreat cancer case report year old man develop weight loss diabet mellitus earli symptom pancreat cancer sever month diagnosi unfortun diagnosi made late stage general diseas symptomat treatment possibl way aim articl warn possibl way pancreat cancer manifest diagnosi determin time tumor local allow resect curat treatment method reason necessari consid presenc pancreat cancer case atyp manifest diabet
|
D010190;D003920
|
T047;T191
|
36,316,207
|
therapi immunoglonulin igg relat diseas igg rd immunoglobulin igg relat diseas igg rd heterogen disord multi organ involv recognis separ entiti begin centuri evolv therapi review paper glucocorticoid first choic drug long administr glucocorticoid connect mani advers effect case combin glucocorticoid immunosuppress agent lower dose glucocorticoid need respons rate higher therapi better toler rituximab drug possibl use monotherapi combin glucocorticoid immunosuppress drug one studi compar two immunosuporess drug mycophenol mofetil cyclophosphamid respons rate similar remiss longer glucocorticoid cyclophosphamid glucocorticoid mycofenolat mofetil compar studi combin various imunossupress drug glucocorticoid publish rituximab high number respons rate monotherapi use combin glucocorticoid immunosuppress rituximab prefer recommend mainten therapi administ month interv case advanc diseas prefer therefor combin rituximab cyclofosphamid dexamethason initi therapi follow mainten rituximab month interv two new drug investig abatacept dupilimab promis result although intens therapi good result therapi earli diagnosi irrevers fibrot chang igg rd involv organ still need
|
D000077733
|
T047
|
36,316,206
|
clinic experi use newer antibiot intern medicin alarm rise antibiot resist gram posit gram negat bacteria make maximum use known avail antibiot necessari aim work highlight advantag disadvantag antibiot appear market recent year share clinic experi use intern medicin flucloxacillin antibiot signific antistaphylococc effect signific indic oral form infect skin soft tissu causat agent staphylococcus aureus streptococci intraven variant flucloxacillin noninferior altern oxacillin use sever staphylococc infect includ infect endocard contribut treatment uncompl urinari infect oral antibiot mecilinam fosfomycin advantag wide spectrum good toler possibl use pregnant woman antibiot expand treatment option intraven treatment serious infect caus multidrug resist bacteria ceftazidimeavibactam effect infect caus pseudomona aeruginosa enterobacteria includ produc broad spectrum beta lactamas esbl ampc kpc oxa import advantag ceftolozan tazobactam antipseudomon effect character excel clinic efficaci even serious infect caus pseudomona aeruginosa includ multi resist strain
|
D000900;D005436
|
T121;T195;T109
|
36,316,205
|
evalu medic error hospit environ healthcar inher associ risk patient health one risk associ medic relat error common report advers event analyz root caus medic error effect prevent measur propos reduc likelihood studi aim identifi reason medic administr error determin number medic administr error report describ barrier hinder report
|
D009741
|
T097
|
36,316,204
|
goal blood pressur kidney transplant recipi arteri hypertens frequent condit kidney transplant treatment common agenda follow care retrospect data show treatment arteri hypertens decreas risk kidney graft loss random control trial target blood pressur kidney transplant recipi avail lt mm hg frequent mention valu general class antihypertens drug use import consid time transplant possibl interact immunosuppress drug
|
D016030;D006973
|
T061;T047
|
36,316,203
|
spontan coronari arteri dissect two case report men spontan coronari dissect scad one less common caus acut coronari syndrom main affect younger patient without typic risk factor ischem heart diseas scad usual aris sudden otherwis healthi individu previous full qualiti life given potenti urgenc condit import nosolog unit differenti diagnosi chest pain improv avail comprehens diagnost method could see increas number report case thus potenti earli intervent activ prevent complic includ malign arrhythmia cardiac arrest therefor necessari think scad examin patient yet cardiovascular risk vast major publish case report relat case describ women articl describ two case report men
|
D003330;D014652
|
T019;T047
|
36,316,202
|
chronic lung diseas sleep sleep vital import part life qualiti quantiti influenc physiolog process organ relationship lung diseas sleep bidirect lack qualiti sleep worsen compens cours diseas time chronic lung diseas negat affect sleep qualiti coexist sleep disord breath lung disord anoth import issu discuss case chronic obstruct pulmonari diseas overlap sleep disord breath character higher preval hypercapnia overal wors prognosi moreov grow bodi evid possibl link sleep disord breath lung fibrosi tumor complex healthcar patient respiratori diseas omit sleep examin
|
D012891;D029424
|
T047
|
36,316,201
|
sglt inhibit use tool treatment heart failur reduc preserv eject fraction heart failur high preval popul long term point view diseas still difficult treat although number medicin solut offer treatment still larg reserv drug portfolio recent expand includ use sglt inhibitor initi failur reduc also preserv eject fraction question possibl use substanc discuss text focus possibl explan therapeut benefit
|
D000077203;D006333;D003924
|
T121;T047;T046;T109
|
36,316,200
|
risk heart rate various stage cardiovascular continuum prevent detect treatment high blood pressur remain import public health challeng convinc evid heart rate import risk factor cardiovascular diseas recommend rest heart rate measur rough use blood pressur measur usual made session across differ part cardiovascular diseas continuum differ heart rate threshold identifi elev heart rate identifi patient hypertens high cardiovascular risk one import caus inadequ blood pressur control time heart rate control poor adher patient treatment necessari individu treatment patient elev heart rate throughout cardiovascular continuum fix dose combin decreas risk medic non complianc consid patient chronic condit like hypertens improv medic complianc translat better clinic outcom
|
D002318;D006973
|
T047
|
36,316,199
|
comprehens approach patient arteri hypertens dyslipidemia arteri hypertens togeth dyslipidemia diabet smoke sever risk factor cardiovascular cv diseas czech republ among countri high risk cardiovascular diseas reduc cardiovascular mortal morbid patient comprehens approach treatment case aggress control risk factor need articl summar current diagnost therapeut procedur arteri hypertens dyslipidaemia well concept vascular age help us communic cv risk patient
|
D050171;D006973;D002318;D003920
|
T047;T046
|
36,316,198
|
earli gastric cancer earli gastric cancer defin histopatholog tumour limit local progress mucosa submucosa concept earli cancer develop japan wide accept term earli gastric cancer includ case withwithout metastat lymph node involv howev common characterist favour prognosi diseas task endoscopist primarili diagnos identifi tumour precancer lesion verifi biopsi success identif must follow correct classif lead choic adequ approach includ surveil endoscop treatment resect surgic treatment without chemotherapi method treatment determin primarili natur risk lymph node involv
|
D013274
|
T191
|
36,316,197
|
current trend diagnosi pancreat cancer pancreat ductal adenocarcinoma pdac dread malign dismal year surviv rate despit maxim effort optim treatment strategi current earli detect consid effect way improv surviv radic resect potenti cure pdac often divid four categori base extent diseas resect borderlin resect local advanc metastat unfortun major patient diagnos local advanc metastat diseas render inelig curat resect main due lack vagu symptom diseas still local although appropri util prompt avail adequ diagnost tool also critic given aggress natur diseas cost effect biomark high specif sensit allow earli detect pdac without need advanc invas method still avail leav diagnosi depend radiodiagnost method endoscop ultrasound summar latest epidemiolog data risk factor clinic manifest current diagnost trend implic pdac focus serum biomark imag modal addit date manag therapeut algorithm outlin
|
D010190;D021441
|
T191
|
36,316,196
|
endoscop treatment earli colorect cancer earli colorect neoplasia local precancer lesion larg intestin associ neglig risk lymphat system dissemin earli neoplasia consist adenoma low high grade dysplasia intramucos carcinoma superfici invas cancer without high risk featur major case earli neoplast lesion detect colonoscopi treat mean endoscopi resect replac surgic treatment risk invas cancer stratifi diagnost colonoscopi use morpholog classif appropri resect techniqu endoscop polypectomi endoscop mucos resect endoscop submucos dissect full thick resect use success endoscop resect assess histolog examin resect specimen case addit surgic resect lymphadenectomi perform colonoscop surveil need due risk local recurr metachron lesion
|
D000069916;D015179;D000236;D002277
|
T061;T191
|
36,316,179
|
circadian rhythmic vital sign intens care unit discharg outcom traumat brain injuri physiolog function circadian rhythmic often disrupt ill
|
D010351;D000070642
|
T058;T037
|
36,316,178
|
echocardiograph predict success wean venoarteri extracorpor membran oxygen wean venoarteri extracorpor membran oxygen va ecmo support fail patient
|
D015199
|
T061
|
36,316,177
|
prevent tracheostomi relat pressur injuri systemat review meta analysi critic care environ individu undergo tracheostomi high suscept tracheostomi relat pressur injuri
|
D014139;D016638
|
T061;T047
|
36,316,176
|
interprofession team collabor work environ health us intens care unit safe reliabl high qualiti critic care deliveri depend upon interprofession teamwork
|
D001291;D017132
|
T082;T041
|
36,316,174
|
patient famili describ major medic treatment longer live exist life sustain treatment becom avail need provid patient famili clariti treatment increas littl known patient famili conceptu life support
|
D003142;D003657
|
T080;T170;T054;T097;T041
|
36,316,173
|
implement modif development care round cardiac intens care unit interprofession team texa children hospit design institut development care round better coordin development appropri care within cardiac intens care unit first year conduct development care round patient round famili particip greater sinc incept round undergon sever modif includ chang patient select criteria team role deleg import structur round evolv promin integr famili member perspect experi lesson learn development care round form foundat implement development appropri practic initi throughout hospit heart center
|
D056164
|
T065;T058
|
36,316,166
|
construct strategi develop trend antibacteri surfac construct antibacteri surfac effici way respond problem microbi contamin review first describ format process characterist microbi contamin current research status antibacteri surfac passiv antiadhes activ kill combin construct strategi antibacteri surfac discuss detail base differ antibacteri mechan exist problem current antibacteri strategi discuss futur develop trend next generat antibacteri surfac
|
D000900
|
T121;T195
|
36,316,165
|
mussel adhes fundament perspect factor govern strong underwat adhes protein base underwat adhes marin organ exhibit extraordinari bind strength high salin base util varieti molecular interact mechan includ acid base interact bident bind complex hydrogen bond interact electrochem manipul interfaci bond perspect briefli review recent progress field discuss interfaci electrochemistri vari interfaci forc concert tune surfac charg hydrat forc tune interfaci ion concentr discuss open question controversi find new path understand util redox protein deriv polym enhanc underwat adhes complex salt environ
|
D000269;D049872
|
T204;T073;T167
|
36,316,151
|
digit health technolog appli pharmaceut industri improv access noncommunic diseas care low middl incom countri limit research digit health technolog dhts use promot access care patient noncommunic diseas ncds particular low middl incom countri lmic describ use dhts pharmaceut industri led access program aim improv access ncd care lmic
|
D000073296
|
T047
|
36,316,150
|
qualit examin role influenc mother law young marri coupl famili plan rural maharashtra india unmet need famili plan fp continu high india especi among young newli marri women mother law mil often exert pressur coupl fertil control decis make behavior around fertil fp yet pauciti literatur understand perspect ten focus group discuss fgds carri mil young marri women age year particip coupl focus fp intervent part cluster random intervent evalu trial charm studi rural maharashtra india fgds includ question role attitud decis make around fertil fp audio record data translatedtranscrib english analyz key theme use deduct code method mil report social norm earli fertil son prefer understood famili size norm lower among daughter law space benefici support short term contracept especi first child prefer femal steril oppos abort apprehens around side effect contracept use misconcept intrauterin devic particular concern around coerciv insert mil most believ decis make done joint husband wife elder consult involv decis make process find highlight need engag mil fp promot rural india potenti util social norm intervent
|
D005193;D018454
|
T033;T058;T099
|
36,316,148
|
cross last mile tb care rural southern madagascar multistakehold initi despit free tb care polici access tb care rural madagascar limit due mark underfund health care system world health organ estim year tb incid madagascar case per peopl half patient tb notifi treat describ develop implement lesson learn intervent improv tb care servic remot rural district southern madagascar involv nation region local stakehold assess multifacet challeng remot rural area codesign activ address overarch principl intervent promot nation tb guidelin build best practic priorit low cost activ enabl scale depth assess challeng access deliv tb care result follow priorit activ foster communiti engag decentr servic provis improv qualiti care provid nutrit support ensur staff support supervis intervent launch septemb ongo octob mobil tb clinic conduct septemb decemb presumpt patient screen diagnos tb base offici tb notif data calcul trend adjust addit tb notif intervent result fold increas case intervent district tb notif rate increas case per peopl case per peopl involv stakehold level care perceiv key success unexpect increas number patient tb intervent district overburden current paper base tb notif system emphas need expand diagnost social support servic
|
D014376
|
T047
|
36,316,147
|
multisector combin hiv prevent adolesc girl young women qualit studi dream implement trajectori zambia identifi solut implement challeng dream determin resili empow aid free mentor safe women partnership zambia studi examin rollout evolut dream partnership implement
|
D015658
|
T047
|
36,316,146
|
bottleneck solut implement dream program adolesc girl young women namibia synthes implement bottleneck experienc implement dream determin resili empow aid free mentor safe program hiv prevent intervent adolesc girl young women agyw namibia bottleneck organ follow agyw program compon
|
D015658;D065129;D019380
|
T061;T121;T047
|
36,316,145
|
communiti health worker program outcom diabet hypertens control west bank refuge camp retrospect match cohort studi communiti health worker chw program proven effect improv diabet control mani locat set data feasibl efficaci lack middl east set chronic violenc palestinian chw program health palestin hp address chronic diseas west bank refuge camp studi assess feasibl effect program diabet hypertens intervent
|
D003920;D006973
|
T047
|
36,316,144
|
tale countri implement cold chain equip optim platform guinea kenya gavi cold chain equip optim platform cceop approv launch recognit fact function cold chain equip cce essenti strengthen vaccin suppli chain ultim achiev gavi immun equiti coverag goal cceop gavi commit invest us million commiss cce facil upgrad expand cce footprint stimul market provid afford technolog advanc access equip present case studi guinea kenya receiv cceop support highlight way countri priorit invest implement activ larg fund support mechan studi explor differ way countri implement cceop consid aspect leadership technic capac influenc countri prioriti result also uncov key lesson sustain larg immun suppli chain effort experi guinea kenya help countri embark similar larg health system intervent especi relat suppli chain strengthen immun program particular experi offer import lesson leadership process system countri ownership technic capac sustain
|
D012034;D007391
|
T064;T066
|
36,316,143
|
communiti health worker improv hiv disclosur among hiv affect sexual partner rural uganda quasi experiment studi evalu efficaci communiti health worker chw led intervent support disclosur among adult live hiv heterosexu relationship
|
D012747;D015658
|
T033;T047;T098
|
36,316,142
|
earli reflect mphatlalatsan matern neonat qualiti improv initi implement covid south africa despit global progress reduc matern neonat mortal stillbirth much work remain done achiev sustain develop goal report indic coronavirus diseas covid disrupt provis uptak routin matern neonat health care mnh servic negat impact cumul pre covid achiev describ multipartn mnh qualiti improv qi initi call mphatlalatsan implement south africa covid pandem initi aim reduc matern mortal ratio neonat mortal rate stillbirth rate multifacet design compris qi intervent activ across micro meso macrolevel area base approach facilit patient access mnh servic initi commenc month pre covid subsequ adapt necessit covid initi focus plan studi act qi model shift toward meet immedi need health care worker hcws health system health care manag aris covid exampl includ provid emot support staff streamlin suppli chain manag infect control person protect materi need address mphatlalatsan gradual refocus hcws manag attent recogn disrupt caus covid routin mnh servic gradual repriorit includ develop risk matrix help staff manag identifi specif risk servic provis uptak develop mitig measur approach mphatlalatsan led optim case use exist resourc rather request new resourc build invest case respons design implement approach cornerston initi mphatlalatsan demonstr agil context specif respons crise covid pandem mitig threat maintain intervent improv mnh servic
|
D000086382;D008427
|
T047;T058;T067
|
36,316,141
|
lesson learn integr infant young child feed counsel iron folic acid distribut routin immun servic ethiopia immun program reach children communiti health intervent thus make immun promis platform integr essenti health servic dearth literatur integr nutrit intervent infant young child feed iycf counsel iron folic acid ifa supplement routin immun servicesto address evid gap month pilot studi august novemb test feasibl integr iycf counsel ifa supplement distribut immun servic deliveri ethiopia intervent focus joint microplan integr servic includ estim target popul servic revis client flow servic deliveri provid job support hws implement monitor integr servic deliveryfind suggest plan deliv iycf counsel ifa supplement immun servic feasibl integr servic provid opportun collabor plan enabl health worker hws offer multipl servic client interact howev hws felt addit human resourc need manag integr servic especi integr outreach mobil servic deliveri hws also report communiti appreci access servic visit express reserv longer wait timescountri may consid expand fix outreach immun servic provid integr servic deliveri provid feasibl sustain high qualiti incorpor care plan follow increas human financi resourc need reinforc new practic expand access broader array health servic
|
D003376;D005492
|
T121;T058;T127;T109
|
36,316,140
|
develop test chatbot integr hiv educ famili plan clinic wait area lusaka zambia maxim protect unintend pregnanc hiv import famili plan fp servic integr hiv counsel support method choic identifi potenti hiv servic interest pre exposur prophylaxi prep howev fp provid often lack suffici time knowledg address hiv vulner client potenti offload initi hiv counsel burden fp provid develop test chatbot provid inform hiv dual protect fp client wait area fp clinic lusaka zambia
|
D015658;D065129
|
T061;T047
|
36,316,139
|
willing pay hiv prevent commod among key popul group nigeria key popul kp group femal sex worker men sex men nigeria reli free hiv prevent commod includ pre exposur prophylaxi prep hiv self test hivst kit provid foreign aid investig willing kp group use pay hiv prevent commod support improv sustain hiv prevent program
|
D060386;D000072339;D000163;D015658
|
T047;T098;T097
|
36,316,138
|
chang child undernutrit overweight india ecolog analysi state evalu chang prioriti indic child growth examin role human develop measur chang
|
D015362;D044342
|
T047
|
36,316,137
|
improv qualiti health care special neonat care unit india intervent studi evalu efficaci train health care worker hcws point care qualiti improv pocqi preterm newborn health care packag phcp follow remot mentor support supervis improv health care practic neonat surviv morbid special neonat care unit sncus
|
D003695;D000071252
|
T065;T058;T093
|
36,316,136
|
learn implement share learn agenda access strategi hormon intrauterin devic global learn agenda hormon intrauterin devic iud develop prioriti research question regard use method low middl incom countri addit member hormon iud access group align strategi expand access context volunteer contracept method choic articl synthes evid generat sinc describ step taken address demand suppli side barrier access find demonstr high continu rate satisfact among hormon iud user compar long act revers contracept larc across studi sizabl number user report would chosen short act method method hormon iud option suggest women see hormon iud interchang larc option thus may fill import nich market sever countri pois scale method resourc mobil key demand side invest implement research critic understand best launch scale method ensur sustain multipl qualiti assur supplier afford public sector price necessari suppli side
|
D000073919;D007434;D003271
|
T065;T121;T074
|
36,316,135
|
financi implic tariff medic oxygen rwandan public hospit financ manag coronavirus epidem rwanda provid reimburs oxygen base durat patient consumpt fix hour tariff rate studi sought assess whether current insur tariff rwanda adequ cover cost oxygen use oxygen therapi explor altern tariff modelsth assess found hospit make margin surplus low volum flow rate patient incur loss patient requir high volum flow rate high volum nonspeci hospit larg pool patient consum medic oxygen low flow rate usag patient eg neonat tend subsid high flow usag patient surgeri number patient consum low flow oxygen higher latter studi found current tariff suffici exponenti surg demand high flow usag peak covid pandem variabl tariff factor durat hour volum liter use therapi may requir work better reflect cost consumpt ward case base payment model provid standard price framework base patient diagnosi intervent intens treatmentthi studi highlight need transit time base tariff structur case base volum base tariff incentiv sustain product provis suppli medic oxygen servic health facil rwanda social health insur reimburs tariff medic oxygen need reflect durat volum consumpt oxygen therapi vari base intervent diseas sever patient age length stay respons treatment
|
D010100;D000086382
|
T123;T121;T067;T196;T047
|
36,316,134
|
meet sexual reproduct health need intern displac person ethiopia somali region qualit process evalu meet sexual reproduct health right srhr need intern displac person idp critic despit increas priorit coverag sexual reproduct health srh servic humanitarian set recent decad signific unmet need remain ethiopia million idp estim unmet need modern contracept address engenderhealth implement model srhr program ethiopia somali region share lesson learn project improv access srh servic among idp
|
D012036;D000086382
|
T047;T098;T067
|
36,316,133
|
comprehens vaccin prevent diseas surveil western pacif region literatur review integr surveil function strateg framework develop world health organ region offic western pacif emphas need high qualiti integr vaccin prevent diseas vpd surveil conduct literatur review document barrier enabl factor innov integr surveil function vpds communic diseas western pacif region wpr countri
|
D000079263
|
T047
|
36,316,132
|
make remov part inform choic mix method studi client experi remov long act revers contracept seneg ensur access remov servic implant intrauterin devic iud essenti realiz inform choic voluntari famili plan document remov desir experi among women receiv implant iud public sector district seneg
|
D007434;D003271
|
T121;T074
|
36,316,131
|
design impact institution appli system think sustain postpartum famili plan approach first time mother bangladesh integr servic deliveri approach shown promis increas use servic includ postpartum famili plan ppfp young first time mother ftms proven challeng scale institution integr add complex requir care assess effect rang key system function demand creation servic deliveri oversight govern innov design process select approach increas ftms ppfp use exist health system generat programmat option sought select approach base potenti impact ftms ppfp uptak potenti institution health system latter repres innov address manag system driver scalabl sustain accomplish develop participatori design process assess potenti approach institution specif contextw adapt manag system theori viabl system model vsm present essenti organiz function relat requir improv viabil perform institution organiz system draw vsm develop process review effect propos approach provid workload client flow infrastructur revis guidelin job descript coordin manag inform system vsm provid structur identifi potenti displac capac health system mitig often neglect organiz challeng compromis institution process inform elimin approach potenti impact deal breaker institution increas workload shift job descript bangladeshi context select approach consider system element foster discuss expect risk institution highlight need mitig effort monitor implement
|
D005193;D009035
|
T033;T092;T058;T099
|
36,316,128
|
associ blood biomark inflamm penumbra consumpt mechan thrombectomi patient acut ischem stroke object studi assess relationship blood biomark inflamm lesion growth within penumbra acut ischem stroke ai patient treat mechan thrombectomi mt
|
D002545;D000083242;D020521
|
T047;T046
|
36,316,116
|
effect estim blood volum bodi mass index gfap nfl level serum csf patient multipl sclerosi increas valid biomark measur multipl sclerosi ms factor affect concentr need identifi test whether volum distribut approxim patient estim blood volum bv bodi mass index bmi affect serum concentr glial fibrillari acid protein gfap control also determin relationship bvbmi gfap concentr csf confirm earlier find test hypothes neurofila light chain nfl
|
D009103
|
T047
|
36,316,097
|
nuclear magnet reson metabolom profil urin chemistri incid kidney stone former compar control urin metabolit chemistri contribut kidney stone format fulli understood studi examin differ urin metabol chemistri profil first time stone former control
|
D007669
|
T047
|
36,316,096
|
data driven chronic allograft phenotyp novel valid complement histolog assess kidney transplant biopsi valid system current exist realist character chronic patholog kidney transplant repres dynam diseas process spectrum diseas sever sought develop valid tool describ chronic sever renal allograft diseas integr evalu diseas activ
|
D016030;D007674
|
T061;T047
|
36,316,095
|
steroid resist nephrot syndrom associ lt gt myoe lt gt mutat differenti effect myosin e local dynam activ myoe nonmuscl motor protein enrich podocyt mutat lt gt myoe lt gt associ steroid resist nephrot syndrom srns lt gt myoe lt gt variant identifi genom sequenc function character set analyz two mutat myoe motor domain ti dh select basi protein sequenc conserv
|
D024461;D009404
|
T047;T126;T116
|
36,316,091
|
differ phosphat parathyroid hormon concentr day among patient hemodialysi elev serum phosphat parathyroid hormon pth concentr associ cardiovascular event bone diseas mortal patient mainten hemodialysi although circadian chang known peopl ckd unknown whether differ occur paramet cours day peopl receiv hemodialysi
|
D010281;D010710
|
T123;T121;T116;T197;T125
|
36,316,084
|
phase iii randomis doubl blind placebo control multicentr trial evalu efficaci safeti rhgad preserv endogen beta cell function adolesc adult recent diagnos type diabet carri genet hla dr dq haplotyp diagnod studi protocol type diabet td autoimmun diseas lead destruct insulin produc beta cell result insulin defici hyperglycaem today approv therapi exist halt detriment immunolog process recent phase b studi intralymphat administr recombin human glutam acid decarboxylas kda rhgad adsorb alhydrogel adjuv individu recent diagnos td carri hla dr dq haplotyp show promis result preserv endogen insulin secret confirm result larg meta analysi three randomis placebo control trial subcutan rhgad aim current precis medicin phase studi determin whether intralymphat administr rhgad preserv insulin secret improv glycaem control presum respond individu recent diagnos td carri hla dr dq
|
D003922
|
T047
|
36,316,083
|
retrospect observ studi influenc covid outbreak infant hospitalis acut bronchiol acut bronchiol major public health issu high number infant hospitalis worldwid year franc hospitalis most occur octob march peak decemb reduct emerg visit bronchiol observ onset covid outbreak aim assess pandem effect hospitalis bronchiol winter covid period compar three previous winter pre covid
|
D001990;D000086382;D001988;D018113;D018357
|
T047;T005;T067
|
36,316,082
|
mechan thrombectomi first versus direct angioplasti stent treatment intracrani atherosclerot stenosi relat larg vessel occlus protocol systemat review meta analysi mechan thrombectomi mt use stent retriev direct aspir first pass techniqu proven yield better result intraven thrombolysi treat acut ischaem stroke caus larg vessel occlus lvo howev treatment intracrani atherosclerot stenosi relat lvo remain unclear critic problem daili clinic practic caus relat high failur rate mt whether direct angioplasti andor stent clinic feasibl show advantag reduc delay revascularis better function outcom compar mt rescu angioplasti andor stent remain unclear studi seek provid direct practic clinic evid clinician
|
D002545;D020521;D002537
|
T047;T046
|
36,316,081
|
develop model share care general practic mental healthcar protocol co product studi mental health ill repres one greatest health burden world well document treatment ill could optimis strengthen collabor general practic specialis mental healthcar servic share care furthermor involv user design new intervent strengthen end user valu sustain key therefor aim studi develop share care intervent co product user
|
D001523;D008605;D058006
|
T058;T091;T048
|
36,316,080
|
retrospect cohort studi assess associ treatment tocilizumab mortal among mechan ventil patient covid assess associ tocilizumab administr clinic outcom among mechan ventil patient covid pneumonia
|
D000086382
|
T047;T067
|
36,316,079
|
lesson learnt implement new model care deliveri allianc govern southern health region new zealand qualit studi explor process implement primari communiti care strategi new model care deliveri allianc govern southern health region new zealand nz
|
D003695;D007857
|
T078;T054;T058;T093
|
36,316,078
|
complex multidisciplinari intervent improv initi medic adher cardiovascular diseas diabet treatment primari care ima crct studi mix method process evalu protocol medic non initi primari non adher persist public health problem increas risk advers clinic outcom initi medic adher ima intervent complex multidisciplinari intervent improv adher cardiovascular diabet treatment primari care empow patient promot inform prescript base share decis make paper present develop implement strategi ima intervent process evalu protocol embed cluster randomis control trial ima crct understand interpret outcom trial comprehend extent implement fidel activ mechan ima intervent context intervent implement work
|
D002318;D003920
|
T047
|
36,316,077
|
effect onlin physic therapi workplac accid relat outcom nurs care worker studi protocol multicentr randomis control trial accord data occup accid common social welfar facil compar industri particular number occup accid result four day absenc work due low back pain lbp fall increas consid problemat although physic therapi demonstr effect prevent lbp fall older adult live communiti randomis control trial examin whether individu onlin physic therapi prevent lbp fall nurs care worker ncw
|
D000062;D017116
|
T184;T047;T067
|
36,316,076
|
public accept covid vaccin among resid saudi arabia cross section onlin studi accept covid vaccin essenti protect world popul stop covid pandem paper aim measur public accept covid vaccin factor may play import role increas accept vaccin futur pandem
|
D000086382;D014612
|
T129;T121;T116;T067;T047
|
36,316,075
|
minim invas versus open total gastrectomi mega studi protocol multicentr randomis control trial drks curat treatment gastric cancer radic gastrectomi lymphadenectomi lad minim invas total gastrectomi mig aim reduc postop morbid use yet wide establish western countri minim invas versus open total gastrectomi first western multicentr randomis control trial rct compar postop morbid follow mig vs open total gastrectomi og
|
D013274;D010535
|
T060;T191;T061
|
36,316,074
|
navig improv surviv vulner patient lung cancer nurs navig symptom monitor exercis studi protocol multicentr randomis control trial low socioeconom posit sep shown strong associ impair lung cancer surviv barrier relat receiv recommend treatment among patient lung cancer low sep may includ advers health behaviour limit physic psychosoci resourc influenc abil react high risk symptom navig healthcar system address under factor drive decis treatment adher treatment follow vulner patient lung cancer develop navig intervent aim randomis control trial investig effect intervent surviv primari outcom lung cancer treatment adher health relat qualiti life psychosoci outcom well health cost process evalu secondari outcom studi popul vulner patient lung cancer
|
D002289;D008175
|
T191
|
36,316,073
|
data inform step care improv youth engag hiv care kenya protocol cluster randomis trial health servic intervent adolesc youth live hiv aylhiv lower retent care adher treatment viral suppress compar adult step care process client assign increas intens servic step accord level need differenti care stabl client access less frequent servic combin step care align need prefer youth promot optim engag care
|
D012107;D015658
|
T062;T096;T170;T081;T047;T169
|
36,316,072
|
canadian anaphylaxi network predict recurr emerg present allerg reaction prepar prospect cohort studi protocol anaphylaxi sever potenti fatal multiorgan system manifest allerg reaction highest incid anaphylaxi children adolesc biphas anaphylaxi ba defin recurr allerg symptom resolut initi reaction report occur case within hour onset initi reaction dilemma physician determin patient resolv anaphylaxi observ ba long guidelin durat postanaphylaxi monitor vari base limit evid unintend negat impact patient safeti qualiti life healthcar resourc object studi deriv prognost model ba develop risk score system inform disposit decis children present emerg depart ed anaphylaxi
|
D000707
|
T047;T046
|
36,316,071
|
extent disabl among paediatr japanes enceph survivor predictor poor outcom retrospect cohort studi north india determin japanes enceph je associ long term function neurolog outcom extent reduc social particip predictor poor outcom among paediatr je survivor
|
D004672;D044342
|
T047
|
36,316,070
|
perform hpv test pap smear via women attend cervic cancer screen kilimanjaro region northern tanzania cross section studi nest cohort concern perform screen approach inform qualiti novel afford screen approach perform well remot area warrant lack inform make difficult prioritis resourc use effort improv cervic cancer outcom aim compar diagnost valu human papillomavirus hpv test self collect sampl pap smear visual inspect cervix acet acid via test detect high grade cervic intraepitheli neoplasia wors cin
|
D002583;D052685;D030361
|
T005;T191;T047
|
36,316,069
|
influenc social network healthcar prepar select procedur health profess educ dutch interview studi health profess educ hpe student often repres popul serv underrepresent non tradit student problemat divers essenti promot excel health educ care studi aim understand percept tradit non tradit student regard facilit barrier prepar hpe select procedur determin role social network decis make prepar appli
|
D003695;D013336
|
T058;T097;T093
|
36,316,068
|
mediat role homebound status depress symptom cognit impair among communiti dwell older adult usa cross section analysi cohort studi depress symptom known modifi factor cognit impair older adult howev pathway depress symptom lead cognit impair well understood studi aim investig whether homebound status defin usual unabl leav home unassist mediat associ depress symptom cognit impair communiti dwell older adult usa
|
D057187;D060825
|
T056;T048
|
36,316,067
|
environment behaviour exposur pathway associ diarrhoea enter pathogen detect month old periurban kenyan infant cross section studi aim studi test whether household environment hygien behaviour condit moder associ diarrhoea enter pathogen detect infant month age kenya pathogen sourc includ latrin access domest anim co habit public food sourc
|
D003967;D012499
|
T090;T184
|
36,316,066
|
effect communiti base rehabilit cbr centr improv physic fit communiti dwell older adult systemat review protocol increas age popul becom substanti challeng healthcar social servic mani asian countri high incid chronic diseas comorbid older popul lead impair function disabl function disabl may result loss independ reduc qualiti life increas care need communiti base rehabilit cbr provid rehabilit improv physic mental social outcom howev limit evid regard effect cbr improv older adult physic fit aim systemat review synthesis evid effect intervent deliv cbr centr physic fit communiti dwell older adult asian countri
|
D057187;D000203
|
T056;T080
|
36,316,063
|
sociodemograph psycholog characterist influenc patient willing particip clinic trial clinic trial fundament develop new medicin patient particip base free consent studi sought identifi psycholog characterist may influenc patient willing particip clinic trial
|
D002986;D010358
|
T062;T058;T081;T080
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.